Reassessment of the definition of castrate levels of testosterone: Implications for clinical decision making

被引:200
作者
Oefelein, MG [1 ]
Feng, A [1 ]
Scolieri, MJ [1 ]
Ricchiutti, D [1 ]
Resnick, MI [1 ]
机构
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Urol, Cleveland, OH 44106 USA
关键词
D O I
10.1016/S0090-4295(00)00793-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Based on methods introduced in the late 1960s and no longer used, serum testosterone level in men after surgical castration was reported to be 50 ng/dL or less. Radioimmunoassay and, subsequently, chemiluminescent methods have supplanted the early analytic methods because of their improved accuracy and ease of testing. The purpose of this study was to define the castrate testosterone level in the era of chemiluminescent testing. Methods. After bilateral orchiectomy, serum testosterone (total) levels were measured prospectively in 35 prostate cancer patients. Results. The median testosterone value in this patient cohort was 15 ng/dL (0.5 nmol/L; 95% confidence interval 12 to 17 ng/dL). Conclusions. In a contemporary series, castrate testosterone should be defined as less than 20 ng/dL (0.7 nmol/L). The important biologic and economic implications are discussed. UROLOGY 56: 1021-1024, 2000. (C) 2000, Elsevier Science Inc.
引用
收藏
页码:1021 / 1024
页数:4
相关论文
共 20 条
  • [1] *AG HLTH CAR POL R, 2000, AHCPR PUBL
  • [2] DETERMINATION OF TESTOSTERONE IN HUMAN PERIPHERAL + ADRENAL VENOUS PLASMA
    BURGER, HG
    KELLIE, AE
    KENT, JR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1964, 24 (05) : 432 - +
  • [3] TESTOSTERONE IN HUMAN PLASMA
    COPPAGE, WS
    COONER, AE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (17) : 902 - &
  • [4] A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA
    CRAWFORD, ED
    EISENBERGER, MA
    MCLEOD, DG
    SPAULDING, JT
    BENSON, R
    DORR, FA
    BLUMENSTEIN, BA
    DAVIS, MA
    GOODMAN, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (07) : 419 - 424
  • [5] Bilateral orchiectomy with or without flutamide for metastatic prostate cancer
    Eisenberger, MA
    Blumenstein, BA
    Crawford, ED
    Miller, G
    McLeod, DG
    Loehrer, PJ
    Wilding, G
    Sears, K
    Culkin, DJ
    Thompson, IM
    Bueschen, AJ
    Lowe, BA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (15) : 1036 - 1042
  • [6] Huggins C, 1941, CANCER RES, V1, P293
  • [7] Studies on prostate cancer II The effects of castration on advanced carcinoma of the prostate gland
    Huggins, C
    Stevens, RE
    Hodges, CV
    [J]. ARCHIVES OF SURGERY, 1941, 43 (02) : 209 - 223
  • [8] Isurugi K, 1989, Nihon Hinyokika Gakkai Zasshi, V80, P1466
  • [9] COMPARISON OF LHRH ANALOG (ZOLADEX) WITH ORCHIECTOMY IN PATIENTS WITH METASTATIC PROSTATIC-CARCINOMA
    KAISARY, AV
    TYRRELL, CJ
    PEELING, WB
    GRIFFITHS, K
    [J]. BRITISH JOURNAL OF UROLOGY, 1991, 67 (05): : 502 - 508
  • [10] LABRIE F, 1993, CANCER-AM CANCER SOC, V71, P1059, DOI 10.1002/1097-0142(19930201)71:3+<1059::AID-CNCR2820711426>3.0.CO